INMD
Get informed when a big investor buys or sells
+ FollowUndervalued by 140.2% based on the discounted cash flow analysis.
| Market cap | $889.23 Million |
|---|---|
| Enterprise Value | $516.13 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.45 |
| Beta | 1.91 |
| Outstanding Shares | 63,401,000 |
| P/E Ratio | 11.21 |
|---|---|
| PEG | -30.73 |
| Price to Sales | 3.04 |
| Price to Book Ratio | 1.52 |
| Enterprise Value to Revenue | 1.38 |
| Enterprise Value to EBIT | 5.27 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.03 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 205.69% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.67%▼ 51.20% |
|---|---|
| Total Invested | $6.23M▼ 98.64% |
| Investors Holding | 17▼ 185.00% |
No data
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ('RF') technology. InMode strives to enable new emerging surgical procedures as we...